Mesoblast | MSB - Assets


Mesoblast reported $782.31M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Avita Medical AUD 56.39M 1.74M Dec/2025
Clinuvel Pharmaceuticals AUD 269.7M 2.05M Dec/2025
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Pacific Edge NZD 17.6M 17.06M Jun/2026
Paradigm Biopharmaceuticals AUD 23.15M 1.42M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Starpharma Holdings AUD 26.17M 746K Dec/2025
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025